Ledger.Open graph →
SEC Form D · filed August 28, 2023

Superluminal Medicines, Inc

Offering
$25.7M
Sold
$25.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Catherine Riesen · Morrisville, NCExecAndrew Levin · BOSTON, MADirectorCraig Randall · BOSTON, MAExecCony D'Cruz · BOSTON, MAExec · Director · PromoterDylan Morris · San Fransicso, CADirectorCatherine Riesen · Morrisville, NCExecAndrew Levin · Boston, MADirectorCraig Randall · BOSTON, MAExecCony D'Cruz · BOSTON, MAExec · Director · PromoterDylan Morris · Palo Alto, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗